Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Novartis' revenue 2007-2018
Novartis AG's total revenue from 2007 to 2018 (in billion U.S. dollars)
This statistic depicts the revenue of multinational pharmaceutical company Novartis from 2007 to 2018. Novartis AG is one of the largest pharmaceutical companies and is based in Basel, Switzerland. In 2018, Novartis generated a total revenue of some 51.9 billion U.S. dollars.
Novartis AG's total revenue from 2007 to 2018 (in billion U.S. dollars)
| Revenue in billion U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Revenue in billion U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
© Statista 2019
About this statistic
Show source
Please be patient - this may take a moment
Description
Source
More information
- Show sources information
- Show publisher information
- Release date
- January 2019
- Region
- Worldwide
- Survey time period
- 2007 to 2018
- Supplementary notes
-
This statistic was assembled from several editions of Novartis' annual report.
* With the 2015 Annual Report, values back to 2011 were restated, as a result of a series of transactions during 2015. - Open this statistic in...
Source
- Show sources information
- Show publisher information
- Release date
- January 2019
More information
- Region
- Worldwide
- Survey time period
- 2007 to 2018
- Supplementary notes
-
This statistic was assembled from several editions of Novartis' annual report.
* With the 2015 Annual Report, values back to 2011 were restated, as a result of a series of transactions during 2015. - Open this statistic in...
Other statistics on the topic
Novartis
+Pharmaceutical Products & Market
Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
+Pharmaceutical Products & Market
Top 10 biotech and pharmaceutical companies based on market cap 2019
+Pharmaceutical Products & Market
Novartis' top drugs based on revenue 2018
+Pharmaceutical Products & Market
R&D spending share of top pharmaceutical companies 2018 and 2024
You only have access to basic statistics.
This statistic is not included in your account!
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate solution including all features.
Prices do not include sales tax.
All Information
in one Presentation
- 46 page/s
- English
- pptx
- Detailed references
Everything On "Novartis" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.Marlene Greenfield
Vice President, Hearst Magazines
- Global positioning
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2019 (in billion U.S. dollars)Top 10 biotech and pharmaceutical companies based on market cap 2019
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
- Top 10 pharmaceutical companies based on R&D spending as revenue share in 2018 and 2024*R&D spending share of top pharmaceutical companies 2018 and 2024
- Net profit per employee of global top 20 pharmaceutical companies in 2018 (in 1,000 U.S. dollars)Net profit generated per employee in top pharmaceutical companies 2018
- Company overview
- Novartis AG's total revenue from 2007 to 2018 (in billion U.S. dollars)Novartis' revenue 2007-2018
- Novartis AG's net income from 2007 to 2018 (in billion U.S. dollars)Novartis' net income 2007-2018
- Dividends paid by Novartis AG from 2009 to 2018 (in billion U.S. dollars)Dividends paid by Novartis AG 2009-2018
- Total number of Novartis AG's full-time employees from 2009 to 2018*Novartis' number of full-time employees 2009-2018
- Revenue distribution
- Novartis AG's revenue from 2014 to 2018, by segment (in billion U.S. dollars)Novartis revenue 2014-2018 by segment
- Novartis AG's revenue from 2016 to 2018, by region (in million U.S. dollars)Novartis' revenue by region 2016-2018
- Percentage of Novartis AG's revenue in 2018, by segment and market*Novartis - revenue 2018 by segment and market
- Percentage of Novartis AG's pharmaceuticals revenue by therapy area in 2018*Percentage of Novartis pharmaceuticals revenue by therapy area 2018
- Novartis AG's top 10 drugs based on revenue in 2018 (in million U.S. dollars)Novartis' top drugs based on revenue 2018
- Research and development
- Novartis AG's expenditure on research and development from 2004 to 2018 (in billion U.S. dollars)Novartis' expenditure on research and development 2004-2018
- Novartis AG's R&D expenditure as a percent of revenue from 2004 to 2018Novartis' R&D expenditure as a percent of revenue 2004-2018
- Novartis AG's spending on research and development by division in 2017 and 2018 (in billion U.S. dollars)Novartis' spending on research and development by division 2017-2018
- Miscellaneous
- Patients reached by products of Novartis AG from 2009 to 2018 (in millions)Patients reached by Novartis AG's products 2009-2018
- Novartis advertising spending in the United States from 2012 to 2018 (in million U.S. dollars)Novartis: ad spend in the U.S. 2012-2018
- Novartis' sales revenue in Spain 2012-2017
- Novartis AG's growth products as percent of pharma revenue 2009-2016
- Novartis AG - doses sold for prevention of major diseases 2013
- Novartis' number of full-time employees by division 2013-2014
- Italy: clinical trials of Novartis 2017, by therapeutic area
- Italy: patients involved in clinical trials of Novartis 2017, by therapeutic area
- Italy: patients involved in clinical trials of Novartis 2017, by region
- Italy: clinical trials of Novartis approved by AIFA 2017, by stage
- Italy: investments of Novartis 2013-2017
- Italy: number of employees of Novartis 2017, by region
- Novartis' number of employees in Spain 2012-2017
- Value of Novartis' investment in Spain 2012-2016
- Novartis' R & D expenditure in Spain 2012-2016
- Annual growth of the global generic market 2009-2015 by region
- Boehringer Ingelheim's distribution of revenue by business 2016-2018
- Global distribution of blood plasma produced by region 2014
- GlaxoSmithKline: expenditure on research and development 2006-2018
- Market price of shares at NSE for GSK Pharmaceuticals Limited in India FY 2018
- FIBC units sold worldwide by end user 2016
- Vulnerabilities in internet applications
- Sobi Anual and sustainability report 2017
- Pharmaceutical industry in Italy
- Pharmaceutical trends in Europe
- Biotechnology in Germany
- Teva - 2018 Form 10-K
- Generic Pharmaceutical Industry Yearbook 2016
- Indicatori Farmaceutici
- PAGB Annual Review 2017-2018
- Novo Nordisk ANNUAL REPORT 2017
- Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans, 2006 to 2013
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
- Demographics
- Economy
- Education & Science
- Politics & Government
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
You can only download this statistic as a Premium user.
You can only download this statistic as a Premium user.
You can only download this statistic as a Premium user.
As a Premium user you get access to the detailed source references and background information about this statistic.
As a Premium user you get access to background information and details about the release of this statistic.
As soon as this statistic is updated, you will immediately be notified via e-mail.
...and make my research life easier.
You need at least a Premium Account to use this feature.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.